About 30 million people around the world have grown legally blind due to retinal diseases. The EPI-RET project has sought for a technical solution for the past twelve years to help these patients.

A retinal prosthesis system can safely, effectively, and reliably restore enough visual function to patients with late-stage retinitis pigmentosa to improve object detection and overall well-being, ...

Elon Musk's Neuralink prepares Blindsight implant human trials by 2026, aiming to restore vision for the blind with FDA Breakthrough Device Designation.

Neural computation scientists have created a software system that is hoped to improve the function of retinal implants significantly: With the aid of the software, the visual prosthesis "learns" to ...

A former science teacher who's been blind for 16 years became able to see letters, discern objects' edges — and even play a Maggie Simpson video game — thanks to a visual prosthesis that includes a ...

The Intracortical Visual Prosthesis (ICVP), an implant that bypasses the retina and optic nerves to connect directly to the brain's visual cortex, has been successfully surgically implanted in the ...

Retinitis pigmentosa and age-related macular degeneration are two significant causes of severe visual dysfunction. In both, the retinal photoreceptors degenerate, preventing successful conversion of ...

SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are ...

The public markets have proven a rocky path for Second Sight Medical Products ($EYES) since strong initial investor enthusiasm peaked just after its November IPO. But ...

Vivani Medical subsidiary Cortigent announced the results of a study evaluating its Orion visual cortical prosthesis system.

Second Sight, the California-based developer of visual prosthetics and retinal implants, will soon begin a feasibility clinical study to assess its Orion cortical visual prosthesis system in human ...

SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are ...